Clinical implications of various follow up strategies after catheter ablation of atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 4, 2007, Pages 458-462

  Arya, Arash ^a   Piorkowski, Christopher ^a   Sommer, Philipp ^a   Kottkamp, Hans ^b   Hindricks, Gerhard ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HerzZentrum Hirslanden Zurich   (Switzerland)

Author keywords

Atrial fibrillation; Catheter ablation; Follow up

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CATHETER ABLATION; DYSPNEA; ELECTROCARDIOGRAPHY MONITORING; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; POSTOPERATIVE PERIOD; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; STROKE; THORAX PAIN; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; FOLLOW-UP STUDIES; HUMANS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REOPERATION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247143753     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00693.x     Document Type: Review

References (31)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001; 285:2370-2375.
2. Oral H, Morady F. How to select patients for atrial fibrillation ablation. Heart Rhythm 2006; 3:615-618.
3. Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A. Characterization of different subsets of atrial fibrillation in general practice in France, The ALFA Study. Circulation 1999; 99:3028-3035.
4. Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device. J Am Coll Cardiol 2004; 42:47-52.
5. Page RL, Tilsch TW, Connolly SJ, Schnell DJ, Marcello SR, Wilkinson WE, Pritchett EL. Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators. Asymptomatic or "Silent" atrial fibrillation. Frequency in untreated patients and patients receiving azimilide. Circulation 2003; 107:1141-1145.
6. Rho RW, Page PL. Asymptomatic atrial fibrillation. Prog Cardiovasc Dis 2005; 48:79-87.
7. Camm AJ, Evans KE, Ward DE, Martin A. The rhythm of the heart in active elderly subjects. Am Heart J 1980; 99:598-603.
8. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96:2455-2461.
9. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994; 74:236-241.
10. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-844.
11. Piorkowski C, Kottkamp H, Tanner H, Kobza R, Nielsen J, Arya A, Hindricks G. Value of different follow up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2005; 16:1286-1292.
12. Defaye P, Dournaux F, Mouton E. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing Clin Electrophysiol 1998; 21:250-255.
13. Bhandari AK, Anderson JL, Gilbert EM, Alpert BL, Henthorn RW, Waldo AL, Cullen MT Jr, et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Am Heart J 1992; 124:381-386.
14. Vasamreddy CR, Dalal D, Dong J, Cheng A, Spragg D, Lamiy SZ, Meininger G, et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2006; 17:134-139.
15. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, et al. AFFIRM Investigators. Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005; 149:657-663.
16. Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm 2005; 2:125-131.
17. Frykman V, Frick M, Jensen-Urstad M, Ostergren J, Rosenqvist M. Asymptomatic versus symptomatic persistent atrial fibrillation: Clinical and noninvasive characteristics. J Intern Med 2001; 250:390-397.
18. Kaufman ES, Waldo AL. The impact of asymptomatic atrial fibrillation. J Am Coll Cardiol 2004; 43:53-54.
19. Oral H, Veerareddy S, Good E, Hall B, Cheung P, Tamirisa K, Han J, et al. Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2004; 15:920-924.
20. Callans DJ. Asymptomatic atrial fibrillation in symptomatic patients. J Cardiovasc Electrophysiol 2004; 15:925-926.
21. Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, Kottkamp H. Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112:307-313.
22. Kottkamp H, Tanner H, Kobza R, Schirdewahn P, Dorszewski A, Gerds-Li JH, Carbucicchio C, et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions trigger elimination or substrate modification: Early or delayed cure? J Am Coll Cardiol 2004; 44:869-877.
23. Oral H, Chugh A, Good E, Sankaran S, Reich SS, Igic P, Elmouchi D, et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation 2006; 113:1824-1831.
24. Senatore G, Stabile G, Bertaglia E, Donnici G, De Simone A, Zoppo F, Turco P, et al. Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol 2005; 45:873-876.
25. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004; 109:327-334.
26. Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, Lamprecht K, et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation. A randomized comparison between 2 current ablation strategies. Circulation 2005; 111:2875-2880.
27. Oral H, Scharf C, Chugh A, Hall B, Cheung P, Good E, Veerareddy S, et al. Catheter ablation for paroxysmal atrial fibrillation: Segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003; 108:2355-2360.
28. Hsieh MH, Ching TT, Lee SH, Lin YK, Tsao HM, Chang SL, Lin YJ, et al. The different mechanisms between late and very late recurrences of atrial fibrillation in patients undergoing a repeated catheter ablation. J Cardiovasc Electrophysiol 2006; 17:231-235.
29. Klemm HU, Ventura R, Rostock T, Brandstrup B, Risius T, Meinertz T, Willems S. Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation. J Cardiovasc Electrophysiol 2006; 17:146-150.
30. Riley MJ, Marrouche NF. Ablation of atrial fibrillation. Curr Probl Cardiol 2006; 31:361-390.
31. Fisher JD, Spinelli MA, Mookherjee D, Krumerman AK, Palma EC. Atrial fibrillation ablation: Reaching the mainstream. Pacing Clin Electrophysiol 2006; 29:523-537.